Psilocybin: a psychedelic alternative to antidepressants?
In November 2022, the largest trial to date of the psychedelic drug, psilocybin, showed that - alongside psychological support - a single 25mg dose could improve the symptoms of treatment-resistant depression for up to 12 weeks. Previous studies have suggested an antidepressant mechanism for psilocybin therapy and have shown that psilocybin is at least as […]